Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
Current Signal: SELL (auto-tracking)
1.59% $41.00
America/New_York / 19 apr 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 519.17 mill |
EPS: | 1.350 |
P/E: | 30.37 |
Earnings Date: | May 02, 2024 |
SharesOutstanding: | 12.66 mill |
Avg Daily Volume: | 0.0555 mill |
RATING 2024-04-19 |
---|
S- |
Strong Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Buy | |
Return On Equity: | Strong Buy | |
Return On Asset: | Strong Buy | |
DE: | Neutral | |
P/E: | Strong Buy | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 30.37 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
0.14x |
Company: PE 30.37 | industry: PE 222.16 |
DISCOUNTED CASH FLOW VALUE |
---|
$38.25 (-6.70%) $-2.75 |
Date: 2024-04-19 |
Expected Trading Range (DAY) |
---|
$ 39.53 - 42.47 ( +/- 3.59%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-26 | Susi Roger E. | Sell | 5 000 | Common Stock |
2023-12-27 | Susi Roger E. | Sell | 5 000 | Common Stock |
2023-12-21 | Susi Roger E. | Sell | 300 000 | Common Stock |
2023-12-18 | Susi Roger E. | Sell | 5 000 | Common Stock |
2023-12-19 | Susi Roger E. | Sell | 5 000 | Common Stock |
INSIDER POWER |
---|
-83.06 |
Last 100 transactions |
Buy: 59 851 | Sell: 665 743 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $41.00 (1.59% ) |
Volume | 0.0461 mill |
Avg. Vol. | 0.0555 mill |
% of Avg. Vol | 83.12 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % | Feb 8 - 15:33 | buy | $46.43 | N/A | Active |
---|
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.